Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Takanawa is a Japan- and Iceland-linked private company group that includes Takanawa Japan K.K. and Takanawa Pharma K.K. In life sciences, the company appears to operate primarily as a pharmaceutical business development, licensing, partnering, and cross-border advisory firm rather than as a drug developer with a disclosed internal therapeutic pipeline. Its pharma team emphasizes relationships with Japanese pharmaceutical companies, support for M&A, joint ventures, licensing, and alliance formation, with particular experience in oncology and healthcare products. Publicly described work includes advising on a licensing deal between Gi-Innovation and Maruho and supporting partnership efforts for Tiziana Life Sciences in Japan and other Asian markets. The broader Takanawa group also operates in skincare, health food, green energy, IT and telecom, and travel tech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Takanawa Japan.